Participated · Equity · Sep 2018

InfoBionic develops the MoMe® ARC platform, a third-generation virtual telemetry system for remote, wireless monitoring and diagnosis of cardiac arrhythmias. Its MoMe® ARC 4-in-1 monitor pairs a 3rd-generation remote ECG device with a Bluetooth diagnostic 6-lead sensor and offers both patch-type and wire-based sensors. The system delivers heartbeat-to-heartbeat, full-disclosure ECG data over the cloud to provide near real-time, hospital telemetry-level access for clinicians. The company recently received FDA approval for the third-generation MoMe® ARC platform. InfoBionic plans to use the Series D proceeds to continue commercial expansion of the MoMe® ARC system. The company is led by CEO Stuart Long. InfoBionic develops the MoMe® Kardia remote cardiac monitoring platform that provides physicians 24/7 on-demand access to full-disclosure Holter, Event, and MCT data via a HIPAA-compliant portal. The system is positioned to replicate in-hospital telemetry data in the outpatient setting and was granted FDA 510(k) clearance in 2015. The company targets an addressable U.S. market estimated at $1.4 billion and recently announced a commercial distribution partnership to enhance market penetration. InfoBionic reports month-to-month subscription growth rates exceeding 35% since this time last year. The completed financing is intended to support continued commercial expansion of the MoMe® Kardia system. InfoBionic develops the MoMe® Kardia system, a cloud-based remote patient monitoring platform for cardiac arrhythmia detection. The platform streams continuous electrocardiogram, respiration and motion data to the cloud for analysis and delivers automated reporting to mobile devices, tablets and web portals. It provides on-demand, actionable monitoring data and analytics for Holter, Event and mobile cardiac telemetry (MCT) directly to physicians. The company is led by Nancy Briefs, President, CEO and Co-Founder. InfoBionic raised a financing round to support commercialization of the MoMe® Kardia system. The articles report the company is based in Lowell, Massachusetts. InfoBionic is an emerging digital health company focused on providing anywhere, anytime access to cardiac event monitoring with improved event detection and clinical efficacy through a lower-cost business model. Its lead product, the MoMe System, is a cloud-based, multi-pass analysis universal remote patient monitoring platform that provides seamless transition between Holter, Event, and Mobile Cardiac Telemetry monitoring modes in one device. MoMe Kardia is positioned to address the roughly $3B worldwide cardiac monitoring market by delivering enhanced analytics and on-demand access to patient data for diagnosis. Proceeds from the recently closed Series B tranche will enable commercialization of the MoMe System in Europe and the United States. The company emphasizes cloud technology to improve patient monitoring, diagnosis and treatment while reducing operating and healthcare costs. Safeguard Scientifics’ participation and board representation signal strategic support for commercialization and growth.

Participated · Series E · Apr 2018

Livongo Health is a Mountain View, California-based consumer digital health company that offers Livongo for Diabetes and Livongo for Hypertension. Led by CEO Glen Tullman, the company combines consumer health technology, personalized recommendations, and real-time support to drive behavior change at the point of impact. Powered by advanced data science, Livongo creates personalized experiences so members receive the right information, tools, and support at the right time. The company announced a $105M funding round and will use the proceeds to accelerate growth, continue investing in data science, deepen integration with clients and partners, and develop its comprehensive consumer platform. Livongo also announced a strategic partnership with Cambia Health Solutions to improve member health beginning with diabetes, and to co-develop and market new offerings. In conjunction with the financing, Kinnevik’s Senior Investment Director Chris Bischoff is joining Livongo’s board of directors. Livongo Health offers a cellular-connected blood glucose monitor coupled with monitoring and coaching services that intervene when readings fall outside normal bounds. Readings are sent to Livongo’s monitoring service, which issues recommendations or connects users to a specialist for high or low values. The company emphasizes rapid human response—aiming to reach users within 90 seconds—and lowers usage barriers by providing free test strips and persistent data storage. Livongo works with self-insured employers and pharmacy benefit providers to distribute its product to patients. Management says the company, a little more than three years old, has demonstrated potential payer savings of up to $100 per member per month. Future plans include international expansion and broadening the platform to manage other chronic conditions such as hypertension and depression. Operational metrics cited include a coach-to-member ratio of roughly one coach per 2,500 members and the need to scale educator staffing as membership grows. Livongo Health offers a diabetes management platform that combines a cellular two-way interactive glucose meter, a smart cloud for personalized analytics, and certified diabetes educators to provide real-time, contextual support. The company pairs technology, data science, and coaching to drive clinical improvement, member satisfaction, and cost savings for payers and employers. Livongo reports rapid adoption among self-insured employers, payers, and healthcare providers and is expanding nationally with existing clients such as Lowe’s. The platform is consumer-directed and designed to integrate patients’ care teams including family and medical professionals. The company intends to use new capital to support growth, accelerate the launch of new products and services, and expand into new market segments. Founded in September 2014 by CEO Glen Tullman, Livongo Health offers a digital chronic disease management platform that began with a diabetes program called Livongo for Diabetes. The company supplies users with a blood glucose smartmeter that uploads biometric data to a cloud-based inference engine using historical data, clinical rules and predictive modeling to generate actionable information. Livongo’s product lets members inform family and care teams in real time and is targeted at people with Type 1 and Type 2 diabetes. The company has signed agreements to provide its program to employees of self-insured employers including Office Depot, Iron Mountain and multiple Fortune 100 companies. Livongo plans to further develop its chronic disease management ecosystem and accelerate adoption of its diabetes program among self-insured employers, healthcare providers and payers. The article notes a $20M Series B financing to support these efforts. Livongo Health builds digital health tools and services to help people with chronic conditions access technology, real-time personalized information, and support from a chosen care team. The company is initially focusing on diabetes and offers an FDA-cleared two-way interactive glucometer, unlimited monitoring supplies, cloud-based analytics, and real-time monitoring and support. Led by Glen Tullman, Livongo has partnerships with HealthCare Partners and self-funded employers including Office Depot. The company is based in Palo Alto and also has operations in Chicago. Livongo expects a number of additional strategic partnerships to be announced in the coming months. Financially, the company recently closed a named financing round (see deal details).

Led · Series B · Jan 2018

Foodsmart operates a telenutrition and food benefits management platform that pairs virtual nutrition counseling from a network of U.S. Registered Dietitians with digital tools to plan personalized meals and order food. The platform enables patients to order from nationwide grocers and local medically tailored food partners, apply for SNAP benefits, and learn cost‑effective shopping strategies. Foodsmart partners with health plans and providers to support people facing chronic disease and food insecurity. The company serves over 2.2 million members through contracts with regional and national Medicaid managed care organizations, Medicare Advantage plans, commercial insurers, and more than 1,000 employers. Founded in 2010 and led by CEO Jason Langheier, Foodsmart is based in San Francisco, California. It intends to use the new funding to expand operations and broaden its business reach. Foodsmart (doing business as Zipongo) is a San Francisco-based personalized telenutrition and foodcare leader. The company offers a fully customizable app-based platform backed by a national network of Registered Dietitians that guides members through personalized journeys to healthier eating. Its platform integrates dietary assessments and nutrition counseling with online food ordering and cost-effective meal planning for whole families, making the most of ingredients at home and on the go. The company describes itself as the world's largest telenutrition and foodcare solution. Foodsmart emphasizes making healthy eating affordable and accessible, a mission highlighted by participation from social impact investors. Financially, the company announced a Series C funding round of more than $25 million. Zipongo, launched in 2014 by CEO Jason Langheier, MD, MPH, provides a Food Benefits Management (FBM) platform that delivers sustained engagement through tools including Health (Digital Dietitian), Cooking (recipes, meal planning, grocery delivery, and discounts) and Restaurants (menus, restaurant ordering, and workplace cafes). The company uses those tools to help people assess and improve their nutrition and engage with food-related benefits. It raised $18M in Series B1 financing to expand the platform beyond wellness toward using food as a first-line therapy to treat chronic disease. Zipongo is developing a new solution called FoodScripts to enable health plans and providers to use food to treat conditions. FoodScripts adds prescriptive, personalized, evidence-based modules addressing hypertension, diabetes, obesity and more. The company plans to roll out an early version of FoodScripts to pilot customers in the early spring. Zipongo provides a software-as-a-service platform that enables digital nutrition coaching for large employers, health plans and health systems, and offers food utility tools for families to select and buy healthy food. Its product suite includes meal planning, recipes, grocery rewards, online grocery ordering, menu coaching and mobile meal ordering for cooking and eating prepared meals. The company serves over 150 companies and the majority of national health plans and wellness platforms. Founded by Jason Langheier, MD, MPH, Zipongo combines coaching and commerce to drive healthier food choices. It has raised $28M in total funding and intends to use the new proceeds to expand operations. The platform targets enterprise and consumer-facing partners to broaden adoption. Zipongo offers a web-based health community and an iPhone app that deliver personalized wellness plans, recipes, and grocery deals. The platform personalizes recommendations by allowing users to opt in and connect electronic medical records via a HIPAA‑secure portal. It integrates loyalty-card discounts at local retailers and is building a digital partner network so users can redeem discounts at their preferred grocery stores. The product focuses on transaction-level support to help families identify and afford healthy options at the point of purchase. Zipongo was in private beta and preparing for a full-scale launch while developing technology to sync shopping history and health data automatically. The team recruited grocery and health-industry veterans as advisers to facilitate integration with national chains.

Participated · Equity · Jan 2017

Arcadia is a healthcare data and analytics company whose platform integrates electronic health records, claims, and other sources to improve clinical quality measures, patient risk stratification, and population health management. The company helps providers and health plans deliver actionable insights to advance care, drive strategic growth, and ensure financial success. Arcadia announced a $125M financing to accelerate platform innovation, expand capabilities, and grow the company. It plans to use the funds to continue expanding its platform, enhance service delivery, and strengthen customer relations to support better care delivery, lower costs, and improved patient outcomes. CEO Michael Meucci said Vista Credit Partners will provide financing and access to the broader Vista ecosystem to help scale Arcadia's HealthTech and enterprise software business. Arcadia is based in Boston, MA. Arcadia is an EHR data aggregation and analytics technology company supporting ambulatory networks taking on risk and transitioning to value‑based care. Its platform integrates data from over 30 EHR vendors, enriches it with claims and operational data, and uses analytics to drive improvements in patient care quality, practice efficiency, and financial performance. The company serves over 60 enterprise customers, including health plans, accountable care organizations, integrated delivery networks, and large independent physician groups. Arcadia plans to use recent growth capital to accelerate product development in its core Arcadia Analytics platform and to expand population health management market activities across the country. The business has shifted from a consulting firm to a technology‑led population health analytics company and has completed two acquisitions: Concordant (2011) and Sage Technologies (2015). Arcadia is led by CEO Sean Carroll and is headquartered in Burlington, Massachusetts, with offices in Seattle, Pittsburgh, and Rockford, Illinois. Arcadia Healthcare Solutions provides EHR data aggregation and analytics technology and services to help ambulatory networks, health plans, accountable care organizations, integrated delivery networks, and large physician groups collect, integrate, and report clinical and claims data. Its core products include the Arcadia Analytics and EHR Connect platforms, which enable customers to implement and optimize EHR platforms and transform physician practices using data-driven insights. The company focuses on supporting both fee-for-service optimization and value-based care performance environments and positions itself to help providers manage population health and improve patient outcomes. Arcadia is led by CEO Sean Carroll, who has over 25 years of experience in the health IT industry. Headquartered outside Boston with offices in Seattle and New York City, Arcadia plans to expand its technology suite, accelerate sales and marketing, and add executive talent using the recent investment.

Participated · Series A · Nov 2016

Cohero Health develops connected care devices and mobile and web applications under its BreatheSmart platform to engage respiratory patients, track medication adherence, and measure lung function. Its product suite includes wireless inhaler sensors, an FDA-cleared mobile spirometer, patient-facing mobile apps with reminders and rewards, and HIPAA-compliant web access for custom data. The company is building a large dataset of respiratory patient demographics, medication utilization, symptoms, pulmonary function, outcomes and costs. Cohero has deployed its platform across more than 25 commercial partnerships, representing over 1 million pediatric and adult asthma, COPD, and cystic fibrosis patients. Led by co-founder and CEO Melissa Manice, PhD, and co-founder and COO Dan Weinstein, the company is a member of StartUp Health, Springboard Enterprises, and Grand Central Tech. It plans to use new funding to grow commercial business development, expand its clinical trial program, and further evolve the BreatheSmart platform. Cohero Health develops connected devices and mobile applications aimed at engaging and empowering respiratory patients by measuring lung function and tracking adherence. Its proprietary platform includes wireless medication inhaler sensors, an FDA-cleared mobile spirometer, patient-facing mobile apps that generate reminders and reward compliance, and HIPAA-compliant servers for custom data access. The company is led by Melissa Manice, PhD, and is a member of StartUp Health, Springboard Enterprises, and Grand Central Tech. Cohero closed a $2M seed funding round to support scaling and commercialization. The company plans to use the funds to scale production of its devices for large customer deployments and to support the full-scale commercial launch of its platform. No operating metrics (revenue/users) were disclosed in the sourced article.